Log In
BCIQ
Print this Print this
 

KarXT, LY246708 plus trospium chloride, xanomeline plus trospium chloride

  Manage Alerts
Collapse Summary General Information
Company Karuna Pharmaceuticals Inc.
DescriptionMuscarinic acetylcholine receptor M1 (CHRM1; HM1) and CHRM4 (HM4) agonist plus a CHRM2 (HM2) and CHRM3 (HM3) antagonist
Molecular Target Muscarinic acetylcholine receptor M1 (CHRM1) (HM1) ; Muscarinic acetylcholine receptor M4 (CHRM4) (HM4)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
PartnerEli Lilly and Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today